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background: To explore why increased access to emergency contraception (EC) failed to reduce pregnancies in a recent randomized
controlled trial.
methods: We used multivariable logistic regression to identify risk factors for unintended pregnancy using data from a trial involving sexu-
ally active women (n ¼ 1490, aged 14–24 years) randomly assigned to either increased access or standard access to EC. We used predictive
modeling to generate estimated pregnancy risk scores for each participant. We then examined EC use among women at low or high baseline
risk of pregnancy.
results: Gravidity, recent history of unprotected sex (within 14 days of enrollment to study) and lower aversion to pregnancy predicted
unintended pregnancy. Women in the increased access group were more likely than women in the standard access group to use EC repeat-
edly. This difference was significantly stronger (P ¼ 0.03) among low risk women than high risk women [Relative risk (RR) 10.0, 95% con-
fidence interval (CI) 6.5–15.4 and RR 5.5, 95% CI 3.8–7.9, respectively].
conclusions: Increased access to EC had a greater impact on women who were at lower baseline risk of pregnancy. This may explain
in part why increased access to EC has had no measurable benefit in clinical trials.
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Introduction
Emergency contraception (EC) was introduced in the early 1990s as an
effective method of post-coital contraception. Levonorgestrel EC has
been well established as an efficacious method of preventing pregnancy
(Task Force on Postovulatory Methods of Fertility Regulation, 1998).
Widespread access to EC was expected to substantially decrease the
incidence of unintended pregnancy in the USA; however, this has not
been realized (Trussell et al., 1992; Finer and Henshaw, 2006). Multiple
studies have failed to demonstrate a difference in unintended pregnancy
rates between women provided with an advanced supply of EC and
women who could obtain it only when needed (Lo et al., 2004; Hu
et al., 2005; Raymond et al., 2006; Walsh and Frezieres, 2006). Yet,
failure of advance provision occurs despite a reported increase in use
and more prompt use of levonorgestrel EC after unprotected coitus.
This paradox has mitigated earlier enthusiasm regarding the public
health importance of EC (Glasier, 2006).
The explanation for this failure remains elusive. We hypothesize
that underlying risk of unintended pregnancy may influence response
to an intervention of increased access to EC. That is, with increased
access to EC, women at lower baseline risk of unintended pregnancy
may use EC differently than women at higher risk.
To investigate this question, we used data from a recent trial of an
intervention designed to optimize access to EC. The intervention of
increased access to EC proved successful in increasing EC use; the
mean number of uses per woman was 5.6 times higher in the
intervention group than in the control group (Raymond et al.,
2006). Despite this increased frequency of EC use, the incidence of
unintended pregnancy was similar between groups (Raymond et al.,
2006). For our analysis, we used predictive modeling to characterize
each participant’s baseline risk of unintended pregnancy as either
high or low. We then evaluated whether the effect of the intervention
on EC use differed between these two risk groups.
Materials and Methods
The trial was conducted between October 2002 and June 2005 at
clinical sites in Nevada and North Carolina. CONSORT guidelines
were adhered to in the design and reporting of the original study
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(Moher et al., 2001). The protocol for this secondary analysis was
approved by the institutional review board at the University of
North Carolina at Chapel Hill.
A full description of the methods has been published (Raymond
et al., 2006). Briefly, 1490 sexually active women aged 14–24 years
who did not desire pregnancy for at least 1 year were enrolled.
Women who planned to use longer acting contraceptive methods
and women who had been pregnant within the past 6 weeks or
were breast feeding were excluded. Demographic, behavioral and psy-
chosocial information were collected from each participant at enroll-
ment. Psychosocial questions addressed perceptions of pregnancy,
sexually transmitted infection and various contraception methods.
The full battery of psychosocial questions and details regarding the
factor analysis methods are presented elsewhere (Weaver et al.,
2008). Participants were then randomized to receive either increased
access or standard access to EC. Participants in both groups were
advised to take a single dose of 1.5 mg levonorgestrel as soon as poss-
ible after unprotected intercourse. Standard access group participants
were informed how to obtain EC from the study site at the usual cost
if needed. Increased access group participants were provided with two
free packages of EC pills at enrollment, and free replacement packages
were provided for each reported use of EC. Participants in both
groups were asked to report each use of EC to the study site. Partici-
pants were followed in the clinic at 6 and 12 months after enrollment.
Pregnancy tests were obtained at those times. Follow-up was equally
high in both groups; 95% of participants in the increased access group
and 94% of participants in the standard access group had a final
contact at 365 days or later after enrollment (Raymond et al., 2006).
All analyses were performed on an intention-to-treat basis. Fifteen
of the 1490 participants provided incomplete or inconsistent data on
baseline variables used in the analysis. Of these 15, we included 10 in
the analysis using derived variables and excluded the other 5 (1 in the
increased access group and 4 in the standard access group) from the
analysis, given inadequate information to derive unknown variables.
We selected 20 baseline variables that were potential predictors of
unintended pregnancy. These variables are listed in Table I and include
four psychosocial factors (‘perceived efficacy of contraception’, ‘aver-
sion to pregnancy’, ‘access to contraception’ and ‘stigma’) derived in a
prior exploratory factor analysis of the psychosocial questions
(Weaver et al., 2008). A predictive logistic regression model was fit
to estimate which set of these baseline variables predicted pregnancy
during the trial. We used the standard access group only to develop
the model in order to eliminate any effect of the intervention. The
initial model included all potential predictors, and was reduced by
sequential elimination of variables. Variables were removed from the
model based on likelihood ratio tests if their significance level was
.0.05. Randomization in the original study had been stratified by
location (Nevada versus North Carolina); thus, location was included
in every model. We assessed the reliability of our final model using the
area under a receiver operating characteristic (ROC) curve and the
Hosmer–Lemeshow goodness-of-fit test. To assess the consistency
of our final variable selection, we used a repeated stepwise elimination
procedure on 500 bootstrap samples. Using the final model, we pre-
dicted pregnancy risk for all participants in both intervention groups.
Lastly, we stratified participants into high risk and low risk of unin-
tended pregnancy using a ROC curve-derived cutoff that jointly opti-
mized sensitivity and specificity of risk classification.
We then used a Mantel–Haenzel test of homogeneity to examine
the association between randomization group and EC use in the
year after enrollment, stratified by pregnancy risk, to see whether
baseline pregnancy risk modified this association. We excluded all
EC uses that occurred within the first day of enrollment from the
analysis since participants often cited obtaining EC as the reason for
their initial clinic visit and therefore many of those EC uses likely
would have occurred in the absence of the intervention. This exclusion
eliminated 128/2057 EC uses in the increased access group and 103/
366 uses in the standard access group. We considered two measures
of EC use over the 1 year of follow-up: ever use (0 versus 1 use) and
multiple use (,2 versus 2 uses) during the study. We used a Cox
proportional hazards model, stratified by location, to evaluate the
association between baseline risk, intervention group and their inter-
action on time to pregnancy. We performed our analyses using
Stata 10.0 software (StataCorp, College Station, TX, USA).
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Advanced EC provision group 478 (50%) 267 (51%)
Nevada study site* 481 (50%) 416 (79%)
Age (years) 19.2 (2.6) 20.0 (2.6)
Hispanic ethnicity 89 (9%) 107 (20%)
Non-white race 192 (20%) 125 (24%)
Married 15 (2%) 61 (12%)
Graduated high school 627 (65%) 358 (68%)
Binge alcohol use past month† 352 (37%) 192 (36%)
Smoker 209 (22%) 195 (37%)
Number of previous
pregnancies*
1.0 (0.2) 1.7 (1.0)
Prior abortion 63 (7%) 153 (29%)
Effective contraceptive use‡ 558 (58%) 161 (31%)
Multiple partners past 6 months 357 (37%) 221 (42%)
STIs over past year 53 (6%) 35 (7%)
Prior EC use 304 (32%) 155 (29%)
Unprotected sex past 14 days* 43 (4%) 335 (64%)
Psychosocial factors§
Efficacy of contraception 0.71 (0.14) 0.63 (0.14)
Aversion to pregnancy* 0.83 (0.18) 0.59 (0.28)
Access to contraception 0.82 (0.19) 0.78 (0.21)
Stigma 0.47 (0.21) 0.43 (0.23)
Data represented n (%) for dichotomous variables and mean (SD) for continuous
variables.
EC: emergency contraception, STI: sexually transmitted infection.
*Variables included in final predictive model.
†Defined as consuming more than five drinks in 1 day during the past month.
‡ Defined as any reported use of oral contraceptive pills, intrauterine device,
contraceptive injections, patch, vaginal ring or vasectomy in the past month.
§Psychosocial factor scores are based on a continuous scale from 0 to 1, with higher
scores indicating stronger response; for example, higher ‘aversion to pregnancy’ values
represent greater aversion to pregnancy.
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Results
A total of 740 women in the standard access group was used to
develop the predictive model for pregnancy risk. Three baseline vari-
ables were significantly predictive of unintended pregnancy: number of
previous pregnancies, history of unprotected sex within 14 days prior
to study enrollment and the psychosocial factor ‘aversion to preg-
nancy’. Our predictive model fit the data well (Hosmer–Lemeshow
goodness-of-fit, P ¼ 0.23; area under the ROC curve ¼ 0.761). Of
the 260 standard access group participants stratified as high risk, 50
(19%) had an unintended pregnancy during the follow-up year. In con-
trast, of the 480 participants stratified as low risk, 20 (4%) had an unin-
tended pregnancy during the study. The distributions of risk scores in
the increased access and standard access groups were similar, reflect-
ing the randomization of the original study (Fig. 1). Of the 1485 par-
ticipants in the analysis, 527 (35%) were designated as high risk
(Table I).
Among both high and low risk women, increased access to EC
increased use compared with standard access (Table II). Baseline preg-
nancy risk did not significantly affect the association between increased
access to EC and ever use of this method (P ¼ 0.48, Table III). In the
high risk group, increased access participants were 2.6 times as likely
to ever use EC as the standard access group, with a similar increased
likelihood [relative risk (RR) ¼ 2.9] among the low risk group.
However, baseline pregnancy risk did significantly modify the associ-
ation between the intervention groups and repeated use of EC (P ¼
0.03, Table III). High risk women in the increased access group
were 5.5 times as likely to use EC repeatedly as high risk women in
the standard access group; low risk women in the increased access
group were 10.0 times as likely to use EC repeatedly as low risk
women in the standard access group.
The relative hazard of unintended pregnancy between randomiz-
ation groups was not significantly modified by baseline risk (Cox pro-
portional hazard, P ¼ 0.81). Among low risk women, those provided
with increased access to EC became pregnant at 0.89 times the rate of
those with standard access [95% confidence interval (CI) 0.47–1.69],
with 18 and 20 pregnancies, respectively. Among high risk women,
Figure 1 Risk score distribution by access group, with receiver
operating characteristic curve-derived risk cutoff.
.................................. ..................................
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Table III Ever and repeated use of EC by risk and access group
Increased access Standard access RR (95% CI)*
n % n %
High risk
Total 267 260
Ever use 198 74 74 28 2.6 (2.1–3.2)
Repeated use 157 59 28 11 5.5 (3.8–7.9)
Low risk
Total 478 480
Ever use 301 63 105 22 2.9 (2.4–3.5)
Repeated use 209 44 21 4 10.0 (6.5–15.4)
RR: relative risk, CI: confidence interval.
*Mantel–Haenzel tests of homogeneity comparing risk ratios for high risk and low risk participants: P-value ¼ 0.48 for ever use, P-value ¼ 0.03 for repeated use.
.......................................................................... ..........................................................................
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Table II Total number of EC uses by access and risk group*
Increased access, n 5 745 Standard access, n 5 740
n Total EC uses Mean EC uses n Total EC uses Mean EC uses
High risk 267 823 3.08 260 124 0.48
Low risk 478 1103 2.31 480 136 0.28
*Excluding EC uses occurring within the first day of enrollment.
Emergency contraception use by pregnancy risk 817
those provided with increased access became pregnant at 0.98 times
the rate of those with standard access (95% CI 0.66–1.45), with 49
and 50 pregnancies, respectively.
No follow-up pregnancy data were collected for 49 of the 1485 par-
ticipants in this analysis. Women missing pregnancy status differed sig-
nificantly in pregnancy risk compared with women with known
pregnancy status. Of the 22 women missing pregnancy information
among the increased access group, 15 (68%) were classified as high
risk. Of the 27 women missing pregnancy status among the standard
access group, 11 (41%) were classified as high risk.
Discussion
In our trial, women at low and high baseline risk of pregnancy
responded differently to an intervention designed to optimize access
to EC. The intervention resulted in increased EC use among both
risk groups, but the increase in repeated use was significantly
greater in low risk women than in high risk women. Indeed, women
at low baseline risk were 10 times more likely to use EC repeatedly
if they received increased access than if they were in the standard
access group. In contrast, the effect of the intervention on repeated
EC use was only half as great among women who had a high baseline
pregnancy risk.
This finding is noteworthy because women at low risk for pregnancy
are arguably the subgroup least in need of a pregnancy reduction inter-
vention. In our analysis, even the 10-fold increase in repeated EC use
produced by the intervention did not result in a significant decrease in
the probability of unintended pregnancy among low risk women. This
differential effect of the intervention by pregnancy risk—specifically, its
relatively poorer success in increasing EC use in the highest risk
women—may partially account for its failure to produce a decrease
in pregnancy incidence in the full trial population.
Why might the intervention have been more effective in increasing
EC use in women at low risk of pregnancy? Our analysis found that low
risk participants were substantially more averse to pregnancy at study
enrollment, and accordingly, they were more likely to be using highly
effective contraceptives and less likely to have recently had unpro-
tected sex. Such women assigned to the increased access group
may have continued this predisposition toward protective behaviors
by taking advantage of the opportunity to increase their EC use. In
contrast, high risk women randomized to the increased access
group may have been less primed to make use of EC even when it
was readily available.
One other explanation for our findings is that the risk profile of par-
ticipants may have changed because of the intervention. Recent ana-
lyses of these same data suggest that women identified as low risk
based on enrollment data, who then received an advanced supply of
EC, may have adopted risk behaviors more consistent with a high
risk participant, secondary to increased reliance upon EC as a contra-
ceptive method (Raymond and Weaver, 2008;Weaver et al., 2008).
Since EC use increased substantially with increased access among
both risk groups without a concomitant decrease in pregnancy inci-
dence, it remains feasible that women provided with an advanced
supply of EC were using EC as a substitute for other more reliable
methods. Under this hypothesis, the intervention may have had two
independent and counteracting effects: increasing EC use among
high risk women as well as increasing risk behaviors among initially
low risk women.
Although follow-up was high, 49 of 1485 (3%) women were missing
pregnancy information at the end of their study year, which may have
contributed to a selection bias. Women missing pregnancy data
among the increased access group tend to have been at high preg-
nancy risk. In contrast, those among the standard access group tend
to have been at low risk. This difference may have led to overestima-
tion of the benefit of the intervention in reducing unintended preg-
nancy in the original analysis.
If advance provision or other increased EC access interventions are
to have a beneficial effect in reducing unintended pregnancy incidence,
they must be targeted toward the women who most need them.
Further research to elucidate reasons why women at high risk of preg-
nancy may be relatively unresponsive to efforts to improve their use of
EC and test resolutions to this problem is critically needed.
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